Cellectis SA (CLLS)
4.74
-0.09
(-1.86%)
USD |
NASDAQ |
Dec 05, 16:00
4.70
-0.04
(-0.84%)
After-Hours: 20:00
Cellectis Shareholders Equity (Quarterly): 100.48M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| EDAP TMS SA | 27.40M |
| DBV Technologies SA | 52.85M |
| Genfit SA | -- |
| Ascendis Pharma A/S | -204.54M |
| Akari Therapeutics Plc | 22.69M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 343.04M |
| Total Liabilities (Quarterly) | 242.57M |
| Debt to Equity Ratio | 1.186 |
| Current Ratio | 1.489 |
| Net Debt Paydown Yield | -0.63% |